NEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of ...
Results Revenue of $882.2 millionGAAP diluted earnings per share of $3.21 and non-GAAP diluted earnings per share of ...
On February 15, 2025, the director of the U.S. General Services Administration (GSA), in his capacity as chair of the Civilian Agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback